Open Access

State of the art - Management of hyperkalaemia in patients with chronic heart failure treated with RAAS inhibitors

Topic: Treatment
Organised by Charité Universitätsmedizin Berlin, supported by an unrestricted educational grant from Vifor Pharma

Congress Session

About the speaker

Professor Patrick Rossignol

University of Lorraine, Vandoeuvre-Les-Nancy (France)
10 presentations
1 follower

6 more presentations in this session

Welcome and introduction

Speaker: Professor S. Anker (Berlin, DE)

Thumbnail

Importance of co-morbidities in patient-centred heart failure care – real-life case presentation

Speaker: Professor S. von Haehling (Goettingen, DE)

Thumbnail

Case-based interactive panel discussion – management of hyperkalaemia.

Speaker: Professor P. Rossignol (Vandoeuvre-Les-Nancy, FR) Professor S. von Haehling (Goettingen, DE) Professor A. Coats (Coventry, GB)

Thumbnail

Case-based interactive panel discussion – management of iron deficiency

Speaker: Professor S. Anker (Berlin, DE) Professor T. McDonagh (London, GB) Professor S. von Haehling (Goettingen, DE)

Thumbnail

State of the art - Screening, diagnosis and treatment of iron deficiency in chronic heart failure

Speaker: Professor T. McDonagh (London, GB)

Thumbnail

Access the full session

Hyperkalaemia and iron deficiency management in 2019 – Making the case for better outcomes and quality of life

Speakers: Professor P. Rossignol, Professor S. Anker, Professor S. von Haehling, Professor P. Rossignol, Professor S. von Haehling...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk